Terlipressin is a synthetic analogue of vasopressin used clinically to treat severe hypotension and complications associated with liver cirrhosis, such as bleeding esophageal varices. This peptide functions… Read more









Terlipressin is a synthetic analogue of vasopressin used clinically to treat severe hypotension and complications associated with liver cirrhosis, such as bleeding esophageal varices. This peptide functions as a potent vasoconstrictor by binding to V1a receptors in vascular smooth muscle, while also exhibiting antidiuretic effects through V2 receptor activation in the kidneys. To ensure regulatory compliance and therapeutic efficacy, pharmaceutical laboratories utilize high-quality reference standards of the active pharmaceutical ingredient, alongside characterized impurities, structural analogues, and stable isotope labelled compounds. These specialized materials are essential for rigorous impurity profiling, method validation, and ongoing quality control during the manufacturing process. By providing a comprehensive suite of compounds, including degradation products and synthetic variants, these analytical tools support the precise identification and quantification of related substances, ultimately upholding the high purity and safety standards required for this life-saving medication.